NFKB1 and B-cell chronic lymphocytic leukemia: In contrast, TLR activation, particularly through CpG oligonucleotides (TLR9 ligands), has been shown to significantly increase the quantity of EVs released by CLL cells via MyD88–NF-κB signaling.